Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
A new drug, suzetrigine, shows promise in clinical trials as a non-addictive, non-opioid treatment for chronic pain.
A new experimental drug, suzetrigine, is in clinical trials as a potential non-opioid treatment for chronic pain, showing early promise in reducing pain from conditions like neuropathic pain and osteoarthritis.
Unlike opioids, it targets specific nerve receptors to block pain signals without causing addiction, sedation, or respiratory depression.
Phase 2 trial results indicate effective pain relief and a favorable safety profile, with larger Phase 3 trials ongoing across North America and Europe.
If further testing confirms its benefits, suzetrigine could offer a safer alternative for long-term pain management, helping address the ongoing opioid crisis.
The drug is not yet approved and may take several years before becoming available.
Un nuevo fármaco, la suzetrigina, se muestra prometedor en ensayos clínicos como un tratamiento no adictivo y no opioide para el dolor crónico.